(Q34061085)

30 July 2017

1 reference

title

The role of dopamine in the mechanism of action of antidepressant drugs (English)

1 reference

30 July 2017

0 references

1

D'Aquila PS

1 reference

30 July 2017

Collu M

2

1 reference

30 July 2017

Gessa GL

series ordinal

3

1 reference

30 July 2017

Serra G

series ordinal

4

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

European Journal of Pharmacology

30 July 2017

1 reference

30 July 2017

405

1 reference

30 July 2017

1-3

1 reference

30 July 2017

365-373

1 reference

Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat.

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Chronic antidepressant drug treatment attenuates motor-suppressant effects of apomorphine without changing [3H]GBR 12935 binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Behavioural response to SKF 38393 and quinpirole following chronic antidepressant treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid delta and dopamine D1 receptor stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Dopamine functions in appetitive and defensive behaviours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Effect of repeated treatment with desipramine in the behavioral "despair" test in rats: antagonism by "atypical" but not "classical" neuroleptics or antiadrenergic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Evidence of dopamine involvement in the effect of repeated treatment with various antidepressants in the behavioural 'despair' test in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Stimulation of dopamine D-2 but not D-1 receptors reduces immobility time of rats in the forced swimming test: implication for antidepressant activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Chronic desipramine enhances the effect of locally applied amphetamine on interstitial concentrations of dopamine in the nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

A comparison of the behavioral effects of minaprine, amphetamine and stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Chronic antidepressant drug treatment reduces turning behavior and increases dopamine levels in the medial prefrontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Effects of chronic treatments with amineptine and desipramine on motor responses involving dopaminergic systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

D1 receptor binding in rat striatum: modification by various D1 and D2 antagonists, but not by sibutramine hydrochloride, antidepressants or treatments which enhance central dopaminergic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Electroconvulsive shock: progressive dopamine autoreceptor subsensitivity independent of repeated treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Repeated tricyclics induce a progressive dopamine autoreceptor subsensitivity independent of daily drug treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Effect of acute and chronic fluoxetine on extracellular dopamine levels in the caudate-putamen and nucleus accumbens of rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Behavioural sensitization of mesolimbic dopamine D2 receptors in chronic fluoxetine-treated rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

The pharmacological and anatomical substrates of the amphetamine response in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Role of alpha receptors in the behavioural supersensitivity to D agonists induced by chronic treatment with imipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

The NMDA receptor antagonist MK-801 prevents imipramine-induced supersensitivity to quinpirole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair animal model of depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Dizocilpine prevents the enhanced locomotor response to quinpirole induced by repeated electroconvulsive shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Role of D1 and α1 receptors in the enhanced locomotor response to dopamine D2-like receptor stimulation induced by repeated electroconvulsive shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Anti-anhedonic actions of the novel serotonergic agent flibanserin, a potential rapidly-acting antidepressant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Enhanced functional responsiveness of the dopaminergic system--the mechanism of anti-immobility effects of antidepressants in the behavioural despair test in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Chronic imipramine reduces [3H]SCH 23390 binding and DA-sensitive adenylate cyclase in the limbic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Selective adenylate cyclase increase in the limbic area of long-term imipramine-treated rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Long-term imipramine effects are prevented by NMDA receptor blockade.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Chronic antidepressant administration fails to attenuate apomorphine-induced decreases in rat striatal dopamine metabolites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Dopamine and melatonin in the nucleus accumbens may be implicated in the mode of action of antidepressant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Repeated administration of antidepressant drugs affects the levels of mRNA coding for D1 and D2 dopamine receptors in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Increased intracranial self-stimulation in rats after long-term administration of desipramine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Desensitization of the D1 dopamine receptors in rats reproduces a model of escape deficit reverted by imipramine, fluoxetine and clomipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Crucial role of D1 dopamine receptors in mediating the antidepressant effect of imipramine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Lack of acute antipsychotic effect of Sch 23390, a selective dopamine D1 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

7 January 2021

SCH 23390 and psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Striatal dopamine autoreceptors uninfluenced by chronic administration of antidepressants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Initiation and adaptation: a paradigm for understanding psychotropic drug action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Chronic treatment with antidepressants decreases the number of [3H]SCH 23390 binding sites in the rat striatum and limbic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Effect of antidepressants on striatal and accumbens extracellular dopamine levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Differential effects of chronic imipramine and fluoxetine on basal and amphetamine-induced extracellular dopamine levels in rat nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Effects of subchronic minaprine on dopamine release in the ventral striatum and on immobility in the forced swimming test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Tianeptine increases the extracellular concentrations of dopamine in the nucleus accumbens by a serotonin-independent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Repeated treatment with imipramine or amitriptyline increases the locomotor response of rats to (+)-amphetamine given into the nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

The influence of repeated treatment with imipramine, (+)- and (-)-oxaprotiline on behavioural effects of dopamine D-1 and D-2 agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Antidepressant drugs given repeatedly change the binding of the dopamine D2 receptor agonist, [3H]N-0437, to dopamine D2 receptors in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Dopamine D2 receptors: a potential pharmacological target for nomifensine and tranylcypromine but not other antidepressant treatments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Cholinergic-dopaminergic interactions and the mechanisms of action of antidepressants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Physiological and pathophysiological roles of excitatory amino acids during central nervous system development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Dizocilpine antagonizes the effect of chronic imipramine on learned helplessness in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Evidence for postsynaptic dopamine agonist effects of B-HT 920 in the presence of the dopamine D-1 agonist SKF 38393.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Antagonism of apomorphine-induced yawning by SCH 23390: evidence against the autoreceptor hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Dopaminergic mechanism of imipramine action in an animal model of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Effects of chronic antidepressant treatment on nigrostriatal and mesolimbic dopamine autoreceptors in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Chronic desipramine enhances amphetamine-induced increases in interstitial concentrations of dopamine in the nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

MK-801 prevents the enhanced behavioural response to apomorphine elicited by repeated electroconvulsive treatment in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Down-regulation of dopamine1 (D1) receptors by chronic imipramine is species-specific.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Chronic but not acute clomipramine alters the effect of NMDA receptor regulation of dopamine release in rat frontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Effects of chronic antidepressant treatment on dopamine-related [3H]SCH 23390 and [3H]spiperone binding in the rat striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Different effects of short- and long-term treatment with imipramine on the apomorphine- and food-induced place preference conditioning in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Transduction of psychosocial stress into the neurobiology of recurrent affective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Effects of antidepressant drugs on the dopamine D2/D3 receptors in the rat brain differentiated by agonist and antagonist binding--an autoradiographic analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Repeated treatment with imipramine potentiates cocaine-induced dopamine release and motor stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Dopamine receptors mediating yawning: Are they autoreceptors?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Are D1 dopamine receptor agonists potential antidepressants?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Chronic imipramine ?reverses? B-HT 920-induced hypomotility in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Role of the mesolimbic dopamine system in the mechanism of action of antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Reduction of extracellular dopamine levels can be dissociated from suppression of exploratory behaviour in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Yawning and suppression of exploration in amphetamine-treated rats, incompatibility with the autoreceptor hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

D1 dopamine receptor binding in mood disorders measured by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Initial increases in extracellular dopamine in the ventral tegmental area provide a mechanism for the development of desipramine-induced sensitization within the midbrain dopamine system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Local 5HT3 receptors mediate fluoxetine but not desipramine-induced increase of extracellular dopamine in the prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Mianserin markedly and selectively increases extracellular dopamine in the prefrontal cortex as compared to the nucleus accumbens of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Chronic desipramine and fluoxetine differentially affect extracellular dopamine in the rat prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Functional antagonists at the NMDA receptor complex exhibit antidepressant actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Antidepressant versus neuroleptic activities of sulpiride isomers on four animal models of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Concomitant administration of MK-801 and desipramine enhances extracellular concentration of dopamine in the rat prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Do antidepressants induce dopamine autoreceptor subsensitivity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

Chronic mild stress-induced anhedonia: a realistic animal model of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900566-5

10.1016/S0014-2999(00)00566-5

7 January 2021

Identifiers

DOI

1 reference

30 July 2017

1 reference